DV 7751A
Latest Information Update: 20 Dec 2000
Price :
$50 *
At a glance
- Originator Daiichi Pharmaceutical
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections